The Latest Trading Price of Ajanta Pharma Ltd is ₹ 2824 as of 30 Apr 15:30
. The P/E Ratio of Ajanta Pharma Ltd changed from 23.9 on March 2021 to 35.7 on March 2025 . This represents a CAGR of 8.36% over 5 yearsThe P/E Ratio of Panjon Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Ajanta Pharma Ltd changed from ₹ 15517 crore on March 2021 to ₹ 32708 crore on March 2025 . This represents a CAGR of 16.08% over 5 yearsThe Market Cap of Panjon Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Ajanta Pharma Ltd for the Dec '25 is ₹ 1399 crore as compare to the Sep '25 revenue of ₹ 1413 crore. This represent the decline of -0.94% The revenue of Panjon Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Ajanta Pharma Ltd for the Dec '25 is ₹ 407.21 crore as compare to the Sep '25 ebitda of ₹ 387.17 crore. This represent the growth of 5.18% The ebitda of Panjon Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Ajanta Pharma Ltd changed from ₹ 245.77 crore to ₹ 273.77 crore over 7 quarters. This represents a CAGR of 6.36%
The net profit of Panjon Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0%
The Dividend Payout of Ajanta Pharma Ltd changed from 12.23 % on March 2021 to 38.28 % on March 2025 . This represents a CAGR of 25.63% over 5 yearsThe Dividend Payout of Panjon Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .
About Ajanta Pharma Ltd
Ajanta Pharma Limited is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa.
The Company is involved in development, manufacturing and marketing of quality finished dosages in domestic and international markets.
It produces a comprehensive range of specialty products targeting different therapeutic segments.
It has strong chronic-focused product portfolio led by a first-to-market strategy and front-end presence which helps it outgrow the market.
The company's business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
The branded generics business is spread in India and more than 30 emerging countries across Africa, CIS, the Middle East and South East Asia.
About Panjon Ltd
Incorporated in Dec.'83 Panjon Limited became public in 1992.
The Company was promoted by Nagin Kothari and Manoj Kothari.
The Company is a leading FMCG company.
It has marked its presence with significant achievements and today commands a remarkable market status.
Panjon today has renowned products like PANJON Tablet , PANJON Balm , PANJON Inhaler, PANJON cough drops, Swad Digestive Drops, Swad Chatpati Drops, Swad Chyawanpra Candy,Percy Masala Candy, Panjon Swad PACHAK range : Shahi Anardana, Special Jeera Goli, Hing Peda, Albela Aam, Khatta Meetha Khajoor, Chatpata Amla, Chulbuli Imli and many more.
The Company manufactures and markets consumer and pharmaceutical products which are low priced and within the reach of the common man.
FAQs for the comparison of Ajanta Pharma Ltd and Panjon Ltd
Which company has a larger market capitalization, Ajanta Pharma Ltd or Panjon Ltd?
Market cap of Ajanta Pharma Ltd is 35,289 Cr while Market cap of Panjon Ltd is 40 Cr
What are the key factors driving the stock performance of Ajanta Pharma Ltd and Panjon Ltd?
The stock performance of Ajanta Pharma Ltd and Panjon Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Ajanta Pharma Ltd and Panjon Ltd?
As of May 3, 2026, the Ajanta Pharma Ltd stock price is INR ₹2824.6. On the other hand, Panjon Ltd stock price is INR ₹23.46.
How do dividend payouts of Ajanta Pharma Ltd and Panjon Ltd compare?
To compare the dividend payouts of Ajanta Pharma Ltd and Panjon Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.